MedicaidAdministrativeMedium impact
Removal of DATA 2000 Waiver Federal Requirement for Prescribing Buprenorphine for Opioid Use Disorder
Maryland Medicaid·MD · Family Medicine, Internal Medicine, General Practice +3 more·Nurse Practitioners
Effective date
Jan 12, 2023
We identified it
Jun 20, 2026
Summary
Federal DATA 2000 waiver requirement for prescribing buprenorphine for opioid use disorder has been eliminated. Providers with DEA Schedule III authority can now prescribe buprenorphine without the X-Waiver, but new providers must update their Maryland Medicaid enrollment through ePREP.
Action Required
For providers newly eligible to prescribe buprenorphine: Submit supplemental application in ePREP with DEA termination letter and Schedule III certificate. Billing team must ensure PCP and OB/GYN providers bill buprenorphine services to participant's MCO, while other providers must register with Behavioral Health Administrative Services Organization for reimbursement.